EQV Ventures Acquisition Corp. II - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated July 3, 2025, reports the consummation of the Initial Public Offering (IPO) by EQV Ventures Acquisition Corp. II, a Cayman Islands-based special purpose acquisition company (SPAC). The company is an emerging growth company with securities trading on the New York Stock Exchange under the symbols EVACU, EVAC, and EVACW.
Key Financial Metrics
- Units Sold: 46,000,000 Units in the IPO (including 4,000,000 from partial over-allotment exercise) and 787,857 Private Placement Units.
- Offering Price: $10.00 per Unit.
- Total Offering Proceeds: $460,000,000 placed in a trust account.
- Trust Account Terms: Funds are held with Continental Stock Transfer & Trust Company. Interest earnings may be used for permitted withdrawals and up to $100,000 in liquidation expenses.
- Warrant Exercise Price: $11.50 per share.
- Revenue/Profit/Cash Flow: The filing does not provide specific revenue, profit, or operating cash flow figures as the company is in the pre-business combination phase.
Material Changes
The primary material change is the transition from a private entity to a public company following the IPO closing on July 3, 2025. An audited balance sheet reflecting the receipt of the $460,000,000 in Offering Proceeds has been issued and is included as Exhibit 99.1.
Outlook, Risks, and Contingencies
- Business Combination Deadline: The company must complete an initial business combination within 24 months from the IPO closing, or an earlier date approved by the board.
- Redemption Rights: Public shareholders have the right to redeem their shares if the company fails to complete a business combination within the specified timeframe or if shareholders vote to amend specific provisions regarding redemption rights.
- Liquidity Contingency: Proceeds in the trust account are generally not released until the completion of a business combination, a shareholder vote on amendments, or the inability to complete a combination within the deadline.
Investor Verification Checklist
- Verify the details of the audited balance sheet included in Exhibit 99.1.
- Confirm the specific terms of the over-allotment option exercise and the identity of the underwriters.
- Review the amended and restated memorandum and articles of association for specific redemption triggers and amendment procedures.
- Monitor the 24-month timeline for the initial business combination.